SCHEMBL17084334

SCHEMBL17084334

CC(=O)O/N=C(\C)c1ccc2c(c1)C(Cc1ccccc1)(Cc1ccccc1)c1cc(C(=O)c3ccccc3C)ccc1-2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 2/20 0.36
▸ MAPK13 O15264 1/20 0.36
▸ MAPK12 P53778 1/20 0.36
▸ MAPK11 Q15759 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ HTT P42858 1/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ CASP3 P42574 1/20 0.35
▸ SENP8 Q96LD8 1/20 0.35
▸ SENP7 Q9BQF6 1/20 0.35
▸ SENP6 Q9GZR1 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ SRD5A2 P31213 1/20 0.34
▸ PDK2 Q15119 2/20 0.34
▸ KMT2A Q03164 2/20 0.33
▸ PPARG P37231 1/20 0.33
▸ PPARA Q07869 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ PKM P14618 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17056227 0.88 ALDH1A1 (0.36) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL29789550 0.88 ALDH1A1 (0.36) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL17877627 0.88 ALDH1A1 (0.36) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL17084350 0.88 ALDH1A1 (0.36) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL18852824 0.86 ALDH1A1 (0.39) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL17056226 0.84 ALDH1A1 (0.34) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL17282533 0.84 ALDH1A1 (0.34) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL19307923 0.82 ALDH1A1 (0.37) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL22236591 0.80 ALDH1A1 (0.33) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL17953240 0.78 PDK2 (0.45) ALDH1A1HTTNPC1L3MBTL1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9684238-B2 Fluorene-type compound, photopolymerization initiator comprising said fluorene-type compound, and photosensitive composition containing said photopolymerization initiator TOKYO OHKA KOGYO CO., LTD. (JP) 2017-06-20 — — US disclosed
US-9684238-B2 Fluorene-type compound, photopolymerization initiator comprising said fluorene-type compound, and photosensitive composition containing said photopolymerization initiator TOKYO OHKA KOGYO CO., LTD. (JP) 2017-06-20 — — US disclosed
US-20150259321-A1 FLUORENE-TYPE COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPRISING SAID FLUORENE-TYPE COMPOUND, AND PHOTOSENSITIVE COMPOSITION CONTAINING SAID PHOTOPOLYMERIZATION INITIATOR DAITO CHEMIX CORPORATION (JP) 2015-09-17 — — US disclosed
US-20150259321-A1 FLUORENE-TYPE COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPRISING SAID FLUORENE-TYPE COMPOUND, AND PHOTOSENSITIVE COMPOSITION CONTAINING SAID PHOTOPOLYMERIZATION INITIATOR DAITO CHEMIX CORPORATION (JP) 2015-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150259321-A1 FLUORENE-TYPE COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPRISING SAID FLUORENE-TYPE COMPOUND, AND PHOTOSENSITIVE COMPOSITION CONTAINING SAID PHOTOPOLYMERIZATION INITIATOR AFF1, AFF2, FTO MAPK14 2630/4885MAPK13 2488/4885MAPK12 3460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback